• Company Type For Profit
  • Contact Email info@biolex.com
  • Phone Number 919.542.9901

Biolex is a clinical-stage biopharmaceutical company that uses their patented LEX SystemSM to develop hard-to-make therapeutic proteins and monoclonal antibodies that have been optimized to enhance their efficacy and potency. The LEX System is a technology that genetically transforms the aquatic plant Lemna to enable the production of biologic

product candidates. Their main product aims at treating those afflicted with Hepatitis C.

Lists Featuring This Company

Closed Health Care Companies (Top 10K)
9,671 Number of Organizations • $83.6B Total Funding Amount • 9,079 Number of Investors
J.P. Morgan Securities Inc. Portfolio Companies
46 Number of Organizations • $37.7B Total Funding Amount • 508 Number of Investors
Closed Southern US Health Care Companies
2,030 Number of Organizations • $11.6B Total Funding Amount • 1,062 Number of Investors
Closed East Coast Health Care Companies
2,506 Number of Organizations • $25.7B Total Funding Amount • 2,114 Number of Investors

Frequently Asked Questions

Where is Biolex Therapeutics's headquarters? Biolex Therapeutics is located in Pittsboro, North Carolina, United States.Who invested in Biolex Therapeutics? Biolex Therapeutics has 20 investors including Investor Growth Capital Limited and Intersouth Partners.How much funding has Biolex Therapeutics raised to date? Biolex Therapeutics has raised .When was the last funding round for Biolex Therapeutics? Biolex Therapeutics closed its last funding round on Dec 19, 2011 from a Debt Financing round.